4//SEC Filing
Blaustein Robert 4
Accession 0001562180-25-000497
CIK 0001710072other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 7:56 PM ET
Size
8.1 KB
Accession
0001562180-25-000497
Insider Transaction Report
Form 4
Blaustein Robert
Chief Development Officer
Transactions
- Award
Stock Options (Right to buy)
2025-01-21+160,000→ 160,000 totalExercise: $27.39Exp: 2035-01-21→ Common Stock (160,000 underlying) - Award
Restricted Stock Units
2025-01-21+30,000→ 30,000 totalExercise: $0.00Exp: 2035-01-21→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on January 21, 2026.
- [F2]1/4th of the shares subject to the option become vested and exercisable on January 21, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0002053149
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 7:56 PM ET
- Size
- 8.1 KB